Richard Makara - 15 Jun 2022 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
VP, Head of Accting;Controller
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Issuer symbol
CARA
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
16 Jun 2022, 17:14:11 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Award $0 +7,500 +123% $0.000000 13,583 15 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of (i) December 31, 2022, or (ii) the appointment of the Issuer's new Chief Financial Officer, subject to the Reporting Person's continued service to the Issuer as of such vesting date.